Tackling the drug-resistance pandemic – 2020 and beyond
Author:
Laura J.V. Piddock
Tags:
Antimicrobial Viewpoint article,
Discovery,
Hit-to-lead,
Lead-to-candidate,
Phase 1,
Phase 2,
Phase 3,
Preclinical development,
Regulatory,
Bloodstream infection,
STI,
MDR,
WHO priority pathogens,
Access,
Stewardship
